The Phospho-CAV2 (Tyr27) Antibody is a rabbit polyclonal antibody that specifically detects endogenous levels of Caveolin-2 (CAV2) only when phosphorylated at tyrosine 27. This antibody does not cross-react with non-phosphorylated CAV2 at this position, making it valuable for studying the phosphorylation status of this protein in experimental systems . The specificity for the phosphorylated form is achieved through careful purification processes that remove non-phospho specific antibodies through chromatography using non-phosphopeptides .
This antibody has been validated for the following applications:
Western Blotting (WB): Primary application with dilution ranges of 1:500-1:1000
ELISA: Secondary application with recommended dilutions of 1:5000 to 1:20000
The antibody has not been broadly validated for immunohistochemistry, immunofluorescence, immunoprecipitation, or flow cytometry applications based on the available data.
For optimal performance and stability:
Ship at 4°C
Upon delivery, aliquot to minimize freeze-thaw cycles
Avoid repeated freeze-thaw cycles as they may denature the antibody and reduce its efficacy
For optimal results in Western blotting experiments:
Sample preparation:
Use fresh tissues or cells when possible
Include phosphatase inhibitors in lysis buffers to prevent dephosphorylation
Maintain cold temperatures during sample preparation
Blotting conditions:
Incubate membranes overnight at 4°C for best signal-to-noise ratio
Use 5% BSA in TBST for blocking and antibody dilution (not milk, which contains phosphatases)
Include positive controls (lysates known to contain phosphorylated CAV2)
Include negative controls (treated with phosphatases)
Detection:
To confirm antibody specificity:
Peptide competition assay:
Pre-incubate antibody with excess phospho-peptide containing the Tyr27 site
This should abolish specific signal in Western blot
Phosphatase treatment:
Treat half of your samples with alkaline phosphatase
The signal should disappear in treated samples
Knockout/knockdown controls:
Use CAV2 knockout or knockdown samples as negative controls
No band should be detected at the expected molecular weight
Stimulus-dependent phosphorylation:
Use treatments known to induce or inhibit CAV2 phosphorylation
Observe corresponding changes in signal intensity
CAV2 Tyr27 phosphorylation appears to be regulated by several kinase pathways:
Src family kinases (SFKs):
Receptor tyrosine kinase (RTK) signaling:
Calcium-dependent signaling:
Phosphorylation at Tyr27 appears to play crucial roles in several aspects of CAV2 biology:
Membrane trafficking:
Phosphorylation may regulate the movement of CAV2 between cellular compartments
May influence the formation or stability of caveolae structures
Protein-protein interactions:
Phosphorylation at Tyr27 likely creates binding sites for proteins containing SH2 or PTB domains
May influence CAV2's ability to interact with signaling molecules or other caveolae components
Relationship to cellular functions:
May influence endocytosis pathways
Could affect signal transduction through caveolae-associated receptors
Recent research suggests connections between caveolins and ion channel regulation. To investigate this relationship:
Co-immunoprecipitation studies:
Functional studies:
Compare channel activity in conditions that promote or inhibit CAV2 phosphorylation
Patch-clamp experiments before and after treatments that affect phosphorylation status
Advanced microscopy:
Use fluorescently tagged constructs alongside phospho-specific antibodies
Investigate co-localization of phosphorylated CAV2 with ion channels
Mutation studies:
Utilize Y27F (non-phosphorylatable) or Y27E (phosphomimetic) mutants of CAV2
Examine effects on channel localization, activity, and membrane dynamics
An interesting parallel is that phosphorylation has been shown to significantly influence voltage-gated calcium channel properties. For example, dephosphorylation of Cav3.2 T-type calcium channels shifts activation and inactivation curves toward more negative potentials by approximately 16-19 mV , suggesting that phosphorylation state dramatically affects channel function.
Multiple bands could appear for several reasons:
Isoforms and post-translational modifications:
CAV2 has multiple isoforms (α and β)
Additional post-translational modifications may alter mobility
Degradation products:
Ensure complete protease inhibition during sample preparation
Fresh preparation of samples can minimize degradation
Cross-reactivity:
Critical controls include:
Positive controls:
Cells or tissues treated with tyrosine phosphatase inhibitors
Systems known to express phosphorylated CAV2
Negative controls:
Phosphatase-treated samples to remove phosphorylation
CAV2 knockdown or knockout samples
Peptide competition assays to demonstrate specificity
Comparative analysis:
Use antibodies against total CAV2 in parallel experiments
Calculate phospho-CAV2/total CAV2 ratios for more accurate assessment of phosphorylation status
For detecting low-abundance phosphorylated proteins:
Sample enrichment:
Consider immunoprecipitation with total CAV2 antibody followed by Western blotting with the phospho-specific antibody
Use phosphotyrosine enrichment techniques prior to analysis
Signal amplification:
Employ highly sensitive chemiluminescent substrates
Consider using signal enhancers specifically designed for phosphoprotein detection
Longer exposure times may be necessary, but be cautious of increased background
Increase phosphorylation status:
Treat samples with phosphatase inhibitors
Use stimuli known to enhance tyrosine phosphorylation (EGF, pervanadate treatment)
The relationship between CAV2 phosphorylation and calcium channel function represents an emerging area of research:
Potential mechanistic connections:
Caveolins may regulate calcium channel trafficking to the membrane
Phosphorylated CAV2 might directly interact with calcium channel subunits
May influence calcium channel clustering in specific membrane domains
Experimental approaches:
Co-immunoprecipitation studies to detect interactions between phosphorylated CAV2 and calcium channel subunits
Electrophysiological studies measuring calcium currents in systems with modified CAV2 phosphorylation
Research has shown that calcium channels like Cav2.1 and Cav2.2 are regulated by phosphorylation events and protein interactions . For example, ankyrin-B associates with Cav2.1/Cav2.2 through a conserved motif in the DII/III loop domain, and mutation of a conserved tyrosine residue in this motif disrupts this association . This suggests tyrosine phosphorylation plays critical roles in channel regulation, potentially involving caveolin-mediated pathways.
To investigate the temporal aspects of phosphorylation:
Time-course experiments:
Stimulate cells with appropriate agonists and collect samples at defined intervals
Western blot with phospho-specific antibody to track phosphorylation levels over time
Live-cell imaging approaches:
FRET-based biosensors designed to detect CAV2 phosphorylation state
Phospho-specific antibody fragments coupled to fluorescent proteins for live detection
Super-resolution microscopy:
Track phosphorylated CAV2 localization with high spatial resolution
Correlate with functional measurements of cellular processes
Potential implications in disease:
Cancer research:
Altered tyrosine phosphorylation is common in many cancers
Caveolin function has been implicated in tumor progression and metastasis
Cardiovascular disease:
Caveolins play important roles in vascular function
Phosphorylation may influence endothelial cell responses to stress or injury
Neurological disorders:
Given the potential role in calcium channel regulation, altered CAV2 phosphorylation might impact neuronal excitability and function
Could be relevant in disorders involving calcium signaling dysregulation
The methodologies for studying these disease connections would include comparing phosphorylation levels between normal and diseased tissues, creating phosphomimetic or phospho-deficient CAV2 mutants, and examining their effects in cellular or animal models of disease.